全球 CBD 寵物用品市場 - 2023-2030 年

市場概述

2022 年，全球CBD 寵物用品市場規模達到5.125 億美元，預計到2030 年將達到29.583 億美元，2023-2030 年的年複合成長率為24.5%。

大麻二酚寵物產品市場是指專注於提供包含大麻二酚（CBD）的各種產品的行業，這些產品主要是為寵物配製的。大麻二酚是從大麻中提取的一種化合物，大麻二酚是大麻花的一種衍生物。大麻二酚以其潛在的治療功效而聞名，並被用於旨在解決寵物眾多健康問題的產品中。這些產品中使用的CBD 來自大麻花，而大麻花中的THC（大麻中的精神活性化合物）含量最低。

CBD 寵物產品不再局限於精油或酊劑。市場已經加速發展，包含了種類繁多的產品，如寵物食品、膠囊、外用藥（乳液或藥膏），甚至還有專門針對幼犬的CBD 食品。產品服務的成長為寵物主人提供了更多的選擇，主要是根據寵物的選擇和願望。

市場動態

消費者對使用CBD 產品傾向的轉變推動了CBD 寵物用品市場的發展

隨著時間的推移，消費者對CBD 的看法也在發生變化。越來越多的人接受CBD 是一種具有潛在健康益處的天然藥物。這種觀念的轉變也延伸到了寵物主人身上，他們越來越願意為自己的寵物探索CBD 產品，從而推動了對CBD 寵物產品的需求。例如，寵物補充劑製造商NaturVet 是亞馬遜上該類產品的銷量冠軍，月收入達100 萬美元。

為寵物使用過CBD 產品的寵物主人所分享的積極經驗和見證在推動消費者傾向於使用CBD 寵物產品方面發揮了重要作用。個人經歷和口碑推薦會讓其他寵物主人了解並產生興趣，從而增加需求。

CBD產品的創新有望促進CBD寵物產品市場的發展

CBD 寵物產品的創新包括開發新的、多樣化的產品選擇。這包括添加了CBD 的食物、精油、膠囊、外用藥等。通過提供多種產品，市場可以滿足不同寵物的喜好和健康需求，擴大客戶群，促進市場成長。例如，品牌Innovative 提供CBD + CBDa 配方，這是一種獨特的CBD 和其他大麻素混合配方，共同發揮最大功效。

CBD 寵物產品側重於有針對性的配方，以解決寵物的特定健康問題。例如，針對關節健康、焦慮緩解或皮膚狀況的產品可為寵物主人提供量身定做的解決方案。有針對性的配方提高了CBD 寵物產品的有效性和吸引力，推動了市場的成長。

CBD 產品監管的不確定性阻礙了CBD 寵物用品市場的發展

各轄區監管不明確或監管不一致會阻礙CBD 寵物產品的市場擴張。如果沒有明確的指導方針，企業在進入新市場或擴大產品供應方面就會面臨挑戰，從而減少成長機會。監管的不確定性會使獸醫專業人士在推薦或認可CBD 寵物產品時猶豫不決。獸醫依賴於明確的指導方針來確保他們向寵物主人推薦的產品的安全性和有效性。缺乏明確的監管規定會導致人們採取謹慎的態度，阻礙CBD寵物產品被更廣泛地接受和採用。

法規不明確會削弱消費者對CBD 寵物產品的信心和信任。在沒有標準化法規的情況下，消費者可能會擔心這些產品的安全性、品質和可靠性。這種信心的缺乏會減緩市場成長，限制消費者嘗試CBD寵物產品的意願。

COVID-19 影響分析

COVID-19 分析包括COVID 前情景、COVID 情景和COVID 後情景，以及定價動態（包括大流行期間和大流行後的定價變化，並與COVID 前情景進行比較）、供求光譜（由於貿易限制、封鎖和後續問題而導致的供需變化）、政府計劃（政府機構為振興市場、部門或行業而採取的計劃）和製造商戰略計劃（此處將涵蓋製造商為緩解COVID 問題而採取的措施）。

目 錄

第1 章：研究方法與範圍

• 研究方法
• 報告的研究目標和範圍

第2章：市場定義與概述

第3章：執行摘要

• 按類型分類的市場摘要
• 按銷售管道分類的市場摘要
• 按地區分類的市場摘要

第4 章：市場動態

• 市場影響因素
  • 促進因素
  • 限制因素
  • 機會
  • 影響分析

第5 章：行業分析

• 波特五力分析
• 供應鏈分析
• 定價分析
• 監管分析

第6 章：COVID-19 分析

• COVID-19 的市場分析
  • COVID-19 之前的情況
  • COVID-19 期間的情景
  • COVID-19 之後的情況
• COVID-19 期間的定價動態
• 供需關係
• 大流行期間與市場相關的政府計劃
• 製造商的戰略計劃
• 結論

第七章：按類型分類

• 食品級
• 治療級

第8 章：按配銷通路

• 零售藥店
• 線上銷售
• 獸醫診所
• 其他

第9 章：按地區分類

• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 歐洲其他地區
• 南美洲
  • 巴西
  • 阿根廷
  • 南美洲其他地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳大利亞
  • 亞太其他地區
• 中東和非洲

第10 章：競爭格局

• 競爭格局
• 市場定位/佔有率分析
• 合併與收購分析

第11 章：公司簡介

• GCH, Inc.
  • 公司概況
  • 產品組合和說明
  • 財務概況
  • 主要發展
• Canna-Pet
• Honest Paws
• HempMy Pet
• Fomo Bones
• HolistaPet
• Pet Releaf
• Joy Organics
• Petco Animal Supplies, Inc.
• Charlotte's Web

第12 章：附錄

Market Overview

Global CBD Pet Products Market reached US$ 512.5 million in 2022 and is expected to reach US$ 2,958.3 million by 2030 growing with a CAGR of 24.5% during the forecast period 2023-2030.

The CBD pet products market refers to the industry focused on offering various products that include cannabidiol (CBD) mainly formulated for pets. Cannabidiol is a compound derived from hemp, a ramification of hashish flowers. CBD is known for its potential therapeutic benefits and is utilized in products designed to address numerous fitness concerns in pets. The CBD utilized in these products is sourced from hemp flowers, which include minimum tiers of THC, the psychoactive compound found in hashish.

CBD pet products are no longer limited to just oils or tinctures. The market has accelerated to include a huge variety of products such as treats, capsules, topicals (lotions or balms), and even puppy-specific CBD-infused foods. This growth of product services affords pet owners with more alternatives to choose from primarily based on their pets' choices and desires.

Market Dynamics

Shifting Consumer Inclination Toward the Usage of CBD Products is Driving the CBD Pet Products Market

Consumer perception of CBD has been changing over time. There is a growing acceptance of CBD as a natural remedy with potential health benefits. This shifting perception extends to pet owners who are becoming more open to exploring CBD products for their pets, driving the demand for CBD pet products. For instance, pet supplement manufacturer NaturVet is the top seller in the category on Amazon with monthly revenue of $1 million.

The positive experiences and testimonials shared by pet owners who have used CBD products for their pets play a significant role in driving consumer inclination towards CBD pet products. Personal stories and word-of-mouth recommendations create awareness and generate interest among other pet owners, leading to increased demand.

Innovation in CBD Products is Expected to Foster the CBD Pet Products Market

Innovation in CBD pet products involves the development of new and diverse product options. This includes CBD-infused treats, oils, capsules, topicals, and more. By offering a wide range of products, the market can cater to different pet preferences and health needs, expanding the customer base and fostering market growth. For instance, the brand Innovative offers CBD + CBDa formula, which is a unique blend of CBD and other cannabinoids that work together to provide the maximum benefits.

CBD pet products focus on targeted formulations that address specific health concerns in pets. For example, products formulated for joint health, anxiety relief, or skin conditions provide tailored solutions for pet owners. Targeted formulations enhance the effectiveness and appeal of CBD pet products, driving the market growth.

Regulatory Uncertainty of CBD Products is Holding Back the CBD Pet Products Market

Regulatory ambiguity or inconsistent regulations across jurisdictions can hinder market expansion for CBD pet products. Without clear guidelines, businesses face challenges in entering new markets or expanding their product offerings, reducing growth opportunities. Regulatory uncertainty can create hesitation among veterinary professionals in recommending or endorsing CBD pet products. Veterinarians rely on clear guidelines to ensure the safety and efficacy of products they recommend to pet owners. The lack of regulatory clarity can lead to a cautious approach, hindering wider acceptance and adoption of CBD pet products.

Unclear regulations can undermine consumer confidence and trust in CBD pet products. Consumers may be concerned about the safety, quality, and reliability of these products without standardized regulations in place. This lack of confidence can slow down market growth and limit consumer willingness to try CBD pet products.

COVID-19 Impact Analysis

The COVID-19 Analysis includes Pre-COVID Scenario, COVID Scenario, and Post-COVID Scenario along with Pricing Dynamics (Including pricing change during and post-pandemic comparing it with pre-COVID scenarios), Demand-Supply Spectrum (Shift in demand and supply owing to trading restrictions, lockdown, and subsequent issues), Government Initiatives (Initiatives to revive market, sector or Industry by Government Bodies) and Manufacturers Strategic Initiatives (What manufacturers did to mitigate the COVID issues will be covered here).

Segment Analysis

The global CBD pet products market is segmented based on product, distribution channel, and region.

By Distribution Channel, the Retail Pharmacies Segment is Estimated to have Significant Growth During the Forecast Period

Retail pharmacies have been gradually accepting and stocking CBD products, including CBD pet products, in response to growing consumer demand. This increased acceptance and availability of CBD pet products in retail pharmacies contribute to their potential for significant growth in this segment. For instance, according to an article published by PPSC Pharmacies, by 2024, CBD will be a 20-billion-dollar industry. This is a perfect opportunity for pharmacies to tap into a product that can not only increase patient outcomes but also their cash profits.

Retail pharmacies have an established distribution network that reaches a wide range of customers. This network allows CBD pet products to be readily accessible to pet owners who visit pharmacies for their own health and wellness needs. The existing infrastructure and reach of retail pharmacies provide a strong foundation for growth in this segment.

Geographical Analysis

Asia Pacific is the Fastest Growing Market in the CBD Pet Products Market

Asia Pacific is home to a large population and a growing middle class with growing disposable income. This demographic shift has brought about a upward push in pet ownership and an increased attention on pet fitness and properly-being. The increasing pet market within the Asia Pacific gives massive increase possibilities for CBD puppy products.

The awareness and acceptance of CBD products, including CBD pet products, are steadily growing inside the Asia Pacific region. As facts and education approximately CBD and its capability advantages come to be more on hand, pet owners have become extra open to exploring CBD as an choice for their pets' health concerns.

Competitive Landscape

The major global players in the market include: GCH, Inc., Canna-Pet, Honest Paws, HempMy Pet, Fomo Bones, HolistaPet, Pet Releaf, Joy Organics, Petco Animal Supplies, Inc., and Charlotte's Web.

Why Purchase the Report?

• To visualize the global CBD pet products market segmentation based on type, distribution channel, and region, as well as understand key commercial assets and players.
• Identify commercial opportunities in the market by analyzing trends and co-development.
• Excel data sheet with numerous data points of CBD pet products market-level with all segments.
• The PDF report consists of cogently put-together market analysis after exhaustive qualitative interviews and in-depth market study.
• Product mapping is available as Excel consists of key products of all the major market players.

The global CBD pet products market report would provide approximately 53 tables, 47 figures and 190 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

• 3.1. Market Snippet, by Type
• 3.2. Market Snippet, by Distribution Channel
• 3.3. Market Snippet, by Region

4. Market Dynamics

• 4.1. Market Impacting Factors
  • 4.1.1. Drivers
  • 4.1.2. Restraints
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19 on the Market
  • 6.1.1. Scenario Before COVID-19
  • 6.1.2. Scenario During COVID-19
  • 6.1.3. Scenario Post COVID-19
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 7.1.2. Market Attractiveness Index, By Type
• 7.2. Food-Grade*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Therapeutic-Grade

8. By Distribution Channel

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 8.1.2. Market Attractiveness Index, By Distribution Channel
• 8.2. Retail Pharmacies*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Online Sales
• 8.4. Veterinary Clinics
• 8.5. Others

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America*
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.2.5.1. The U.S.
    • 9.2.5.2. Canada
    • 9.2.5.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.3.5.1. Germany
    • 9.3.5.2. The U.K.
    • 9.3.5.3. France
    • 9.3.5.4. Italy
    • 9.3.5.5. Spain
    • 9.3.5.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.4.5.1. Brazil
    • 9.4.5.2. Argentina
    • 9.4.5.3. Rest of South America
• 9.5. Asia-Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.5.5.1. China
    • 9.5.5.2. India
    • 9.5.5.3. Japan
    • 9.5.5.4. Australia
    • 9.5.5.5. Rest of Asia-Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

10. Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

• 11.1. GCH, Inc.*
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio and Description
  • 11.1.3. Financial Overview
  • 11.1.4. Key Developments
• 11.2. Canna-Pet
• 11.3. Honest Paws
• 11.4. HempMy Pet
• 11.5. Fomo Bones
• 11.6. HolistaPet
• 11.7. Pet Releaf
• 11.8. Joy Organics
• 11.9. Petco Animal Supplies, Inc.
• 11.10. Charlotte's Web

LIST NOT EXHAUSTIVE

12. Appendix

• 12.1. About Us and Services
• 12.2. Contact Us